Dec 14 Express Scripts Holding Co, the
largest pharmacy benefit manager in the United States, said the
conversation about drug pricing isn't going away, about a week
after President-elect Donald Trump vowed to bring down prices.
Shares of the company, which also signaled it was engaged in
M&A discussions, were down 4 percent at $70.10 on Wednesday.
"It's so early ... I've not seen anything that causes me to
be hugely concerned," said Chief Executive Tim Wentworth, in
response to a question about the impact of the Trump
administration on the industry on a call with analysts.
(Reporting by Natalie Grover in Bengaluru; Editing by Saumyadeb